Board Member at Cidara Therapeutics, Inc.
Scott M. Rocklage, PhD joined 5AM Ventures in 2003 as a Venture Partner and became a Managing Partner in 2004. Dr. Rocklage has over three decades of healthcare management experience with strategic leadership responsibilities that led to FDA approval of three U.S. New Drug Applications (Omniscan(TM), Teslascan and Cubicin), and he has entered multiple drug candidates into clinical trials. Dr. Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, and has also held various R&D positions at Salutar and Catalytica. Dr. Rocklage currently serves as Board Chairman of Relypsa, Rennovia, Kinestral, N ...
Source: RENNOVIA INC on 04/28/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Scott M. Rocklage Ph.D.. More specifically, you'll be able to:
Access over 170,000 executive and board member profiles.
Example: Scott M. Rocklage Ph.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.